- Home
- PLTK vs CNTA Comparison
PLTK vs CNTA Comparison
Compare PLTK & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLTK
- CNTA
- Stock Information
- Founded
- PLTK 2010
- CNTA 2020
- Country
- PLTK Israel
- CNTA United Kingdom
- Employees
- PLTK N/A
- CNTA N/A
- Industry
- PLTK EDP Services
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- PLTK Technology
- CNTA Health Care
- Exchange
- PLTK Nasdaq
- CNTA Nasdaq
- Market Cap
- PLTK 2.6B
- CNTA 2.2B
- IPO Year
- PLTK 2021
- CNTA 2021
- Fundamental
- Price
- PLTK $6.97
- CNTA $16.63
- Analyst Decision
- PLTK Buy
- CNTA Strong Buy
- Analyst Count
- PLTK 8
- CNTA 8
- Target Price
- PLTK $9.00
- CNTA $23.00
- AVG Volume (30 Days)
- PLTK 730.2K
- CNTA 995.7K
- Earning Date
- PLTK 02-27-2025
- CNTA 03-27-2025
- Dividend Yield
- PLTK 5.74%
- CNTA N/A
- EPS Growth
- PLTK N/A
- CNTA N/A
- EPS
- PLTK 0.58
- CNTA N/A
- Revenue
- PLTK $2,536,900,000.00
- CNTA $6,853,000.00
- Revenue This Year
- PLTK $0.47
- CNTA N/A
- Revenue Next Year
- PLTK $8.80
- CNTA N/A
- P/E Ratio
- PLTK $12.00
- CNTA N/A
- Revenue Growth
- PLTK N/A
- CNTA N/A
- 52 Week Low
- PLTK $6.25
- CNTA $7.75
- 52 Week High
- PLTK $9.16
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- PLTK 37.24
- CNTA 48.19
- Support Level
- PLTK $7.18
- CNTA $15.50
- Resistance Level
- PLTK $7.55
- CNTA $18.55
- Average True Range (ATR)
- PLTK 0.18
- CNTA 1.25
- MACD
- PLTK -0.02
- CNTA -0.12
- Stochastic Oscillator
- PLTK 0.00
- CNTA 31.57
About PLTK Playtika Holding Corp.
Playtika Holding Corp is primarily engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It primarily derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.